Aratana announces top-line results for dog osteoarthritis treatment

|About: Aratana Therapeutics (PETX)|By:, SA News Editor

Aratana Therapeutics (PETX) says dogs that received AT-001 in a dose-ranging study of osteoarthritis "demonstrated improvements in pain assessment scores that were statistically significant compared to placebo."

The company plans to move the drug into a pivotal study next year and expects approval in 2016. (PR)